A User’s Guide to Cannabinoid Therapies in Oncology

V. Maida; P.J. Daeninck

doi:10.3747/co.23.3487

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Review

1 December 2016

A User’s Guide to Cannabinoid Therapies in Oncology

and

Division of Palliative Care, University of Toronto, Toronto, ON, Canada

Division of Palliative Care, McMaster University, Hamilton, ON, Canada

Supportive and Palliative Care Program, William Osler Health System, Toronto, ON, Canada

⁴

St. Boniface Unit, Cancer Care Manitoba, St. Boniface, MB, Canada

Curr. Oncol.2016, 23(6), 398-406;https://doi.org/10.3747/co.23.3487

Version Notes

Order Reprints

Abstract

“Cannabinoid” is the collective term for a group of chemical compounds that either are derived from the Cannabis plant, are synthetic analogues, or occur endogenously. Although cannabinoids interact mostly at the level of the currently recognized cannabinoid receptors, they might have cross reactivity, such as at opioid receptors.

Keywords:

cannabinoids; Δ-9-tetrahydrocannabinol; THC; cannabidiol; CBD; medical cannabis; pharmaceutical cannabinoids; marijuana

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

The Risk of Colorectal Cancer Is Not Increased after a Diagnosis of Urothelial Cancer: A Population-Based Study

Emerging Therapies for the Treatment of Relapsed or Refractory Follicular Lymphoma